GlassScriptPhysician profile
Jamie L Powers
NPI 1184265381
$4,133.25
in general payments reported to CMS, 2019-2025
24 companies · $547 in 2025
The $547 reported for 2025 was more than what 76% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $308 · 2022: $562 · 2023: $517 · 2024: $2,198 · 2025: $547.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,002 · Travel and Lodging: $1,261.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,001.78 |
| Travel and Lodging | $1,260.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,639.55 | 2021-2025 | Intracept |
| Abbott Laboratories | $494.14 | 2021-2025 | Proclaim, Eterna |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $389.20 | 2021-2025 | Relistor, Trulance |
| Abbvie INC. | $318.35 | 2021-2025 | |
| Vertos Medical, INC. | $185.45 | 2021-2023 | Mild Device Kit |
| Painteq LLC | $151.89 | 2022-2024 | Painteq |
| Medtronic, INC. | $136.30 | 2022-2025 | Inceptiv, Intellis Adaptivestim |
| Biodelivery Sciences International, INC. | $117.25 | 2021 | |
| Valinor Pharma, LLC | $106.72 | 2023-2024 | Movantik |
| Vertex Pharmaceuticals Incorporated | $88.30 | 2025 | |
| Spinal Simplicity, LLC | $85.89 | 2022-2024 | Ha Minuteman G3-R |
| Relievant Medsystems, INC. | $81.68 | 2023 | Intracept |
| Biotronik Nro, INC. | $56.46 | 2025 | Prospera |
| Spr Therapeutics, INC | $51.81 | 2023-2024 | Sprint Pns System |
| Amneal Pharmaceuticals LLC | $42.12 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $23.36 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $22.80 | 2021 | |
| Pfizer INC. | $22.48 | 2023 | |
| Collegium Pharmaceutical, INC. | $22.39 | 2021 | |
| Saluda Medical Americas, INC. | $20.88 | 2025 | Evoke |
| Ibsa Pharma INC. | $20.64 | 2023 | Licart, Tirosint |
| Stimwave Technologies Incorporated | $19.51 | 2022 | |
| Amgen INC. | $18.96 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $17.12 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Powers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.